C-CAMP has partnered with BIRAC for the Biotechnology Ignition Grant (BIG) Scheme, which funds young companies and individuals to establish proof-of-concept data for their exciting ideas in the field of life sciences
C-CAMP - A BIG Partner
C-CAMP has been chosen as one of the five BIG Partner organizations (apart from IKP Knowledge Park, Hyderabad, Foundation for Innovation and Technology Transfer (FITT), New Delhi, Venture Centre, Pune, SIDBI Innovation & Incubation Centre (SIIC), Kanpur and KIIT Bio-incubator, Bhubaneswar). C-CAMP has been chosen as it has the necessary scientific infrastructure, expertise and high-end platform technology access to nurture early stage inventions through Proof of Concept stage.
Over the last few years, C-CAMP has supported 76 start-ups through the BIG scheme, and close to 100 start-ups through its other activities including bio-incubation, mentorship and other facilitation. C-CAMP start-ups are currently working in the fields of healthcare and medical devices, drug discovery, molecular biology, transgenic model systems, biomaterials, bioenergy, synthetic biology, upstream & downstream processing, agricultural sciences, nutraceuticals etc.
As a mandate from DBT, C-CAMP has been providing high-end technology services and training to academia and industry across several technology platforms. To know more about our technology platforms, please click here .
Access to scientific infrastructure, expertise and cutting edge technology could be vital for BIG applicants. Currently there are a few organizations/individuals that are incubating at C-CAMP and have been also utilizing the technology development and scientific expertise on campus. Additionally, C-CAMP has been involved in technology development in collaboration with academia and industry partners.
C-CAMP BIG awardees
Sea6 Energy Pvt. Ltd.
A young bio-energy company started by a group of graduates from IIT-Madras working on developing end-to-end solution to replace the fossil fuels.Sea6 Energy is guiding its efforts towards low-cost, large scale cultivation of red seaweed on the ocean and developing salt water based biotechnological processes to produce biofuels (ethanol, isobutanol etc.), agricultural biostimulant and phycocolloids from red seaweed. Their first product, AGROGAIN™, is a plant growth stimulant from seaweed extract that is now in the market through their partnership with Mahindra & Mahindra. They have raised private investment from Tata capital and they continue to incubate at C-CAMP, where they have expanded from their 6-member team to around 30 scientists and non-scientific staff.
Pandorum Technologies Pvt. Ltd.
A young Bangalore based start-up working on development of 'programmable' materials/ devices based on bio-inspired modules for applications in healthcare.The company was founded by and is now headed by a couple of Indian Institute of Science graduates. After winning the first prize in the BEST Scheme, they applied for and were granted the BIG scheme funding for taking their idea forward. The material they are trying to develop as a part of the BIG project is a modular elastomeric hydrogel with important applications in drug delivery and wound management amongst others.They are resident incubatees at C-CAMP and have established POC and have received follow-on funding.
Achira Labs Pvt. Ltd.
Achira Labs has developed a proprietary lab-on-chip platform to perform rapid, quantitative and multiplexed immunoassays (protein tests) at a low cost Through the BIG grant they are focussing on development of a simple, affordable and accurate diagnostic test for tuberculosis (TB), based on DNA aptamers that detect multiple TB antigens.Their first product ACIX-100 is a proprietary platform that has been calibrated to perform POC tests for HCG (pregnancy), thyroid hormones, and female fertility hormones. Achira has procured follow-on funding.
Codon Biosciences Pvt. Ltd.
A newly established start-up based in Goa which is into development of enzymes for biomass conversion. They have been funded through the BIG scheme for work that involves enzyme based production of high quality wine from mangoes through enzymatic maceration for high quality juice as starting material. Their aim is to make the most of and produce a valuable product from mangoes that are wasted due to lack of proper utilization, post-harvest.Their first product, “Pomar De Frutas” mango wine is produced exclusively from Alphonso mangoes by using a patented wine-making recipe that involves enzymatic maceration of mango pulp. The wine is golden in color, crisp with a fruity aroma and a long lasting finish.
Western Range Biopharmaceuticals Pvt. Ltd.
A newly Western Range Biopharmaceuticals is an Ahmedabad -based R&D-oriented biotech company committed to develop the advanced therapeutics and diagnostics for cancer by partnering with medical community, patient groups, and scientists.Their BIG-funded project focuses on development of personalized immunotherapy for treatment of cancer using autologous & activated dendritic cells.
Dr. Vikas Mehra is an individual BIG awardee currently incubating at Cluster Innovation centre M.S.University, Baroda.He is focused on generation of a diabody against TNF-alpha and IL17R which can be used as a therapeutic intervention for treatment of psoriasis. The diabody will be generated by linking two highly specific scFV against TNF and IL-17R as opposed to the complex production of large mAbs.
Theramyt Novobiologics Pvt. Ltd.
Started in 2013 and based in Bangalore, Theramyt Novobiologics Pvt Ltd is a biotech company focused on biologics and biobetters. As a part of their BIG-funded project, Theramyt is developing cell line platforms which used for production of functionally improved therapeutic antibodies.
GeNext Genomics Pvt. Ltd.
GNG is a young start-up based in Nagpur working towards the goal of identifying Biomarkers and Drug Targets of MTB infection.Apart from focussed MTB therapeutic research, GNG specializes in Protein Expression, Protein Purification, Recombinant & native Protein Expression, and Monoclonal Antibody Production by producing target specific Antibodies.
InvivoD Solutions Pvt. Ltd.
A Kanpur based start-up which is an outcome of the laboratory research in the area of cancer treatment performedby one of the founders. The company is now focused on translating these findings into a Drosophila-based model system for cancer drug screening. The in vivo drug screening system they are in the process of developing can be very useful for validation before clinical trials.
Nurture Earth R&D Pvt. Ltd.
A young company started in 2010, located in Aurangabad working on nano-magnetic disc based, antibody specific ablation of cancer cells. This technology is which is currently being validated in vitro through BIG funds, is expected to become the basis of a non-surgical procedure for elimination of cancer cells.
Unilumen Photonics Pvt. Ltd.
A young venture currently incubated at IIT Madras that is into on fibre laser systems. As a part of their BIG-funded project they are working on development of a cost-effective fibre laser technology for photoselective surgery with infra-red and visible lasers for use by urologists and ophthalmologists.
An individual entrepreneur, currently incubated at Sir M Visvesvaraya Institute of Technology, Bangalore. He is working on development of commercially viable products such as nutraceuticals, poultry and aqua feed from the wastes of palm oil mills and silk reeling industries.
A Team of two academicians, mentored under Dr. Shams, incubated at Technology Business Incubator (TBI), University of Delhi. They are synthetic biologists working on developing processes for microbial overproduction of 2,3-butanediol from lignocellulosic biomass based on metabolic engineering.
An individual academician from InStem, Dr. Vinod Nayak is incubating at C-CAMP and working on development of an efficient Yeast based system for membrane protein expression by designing a flexible suite of shuttle vectors with multiple promoters and affinity tags for expression and purification.
Dr. Yashoda Ghanekar is an individual academician from InStem incubated at C-CAMP. Her BIG-funded project involves establishment of invertebrate transgenic model systems through modification of lentiviral systems. The use of this technology to genetically manipulate invertebrates would make these model systems ideal for research and preliminary screenings in drug discovery and toxicology studies.
Dr. Shweta Morey is an individual entrepreneur in the process of incorporating her company, INDIABiolabs which is dedicated to researching novel all-natural antimicrobials for the food and pharma industry. Her team is presently incubating at Venture Centre, Pune and through the BIG Schem is working on isolating novel Lactic Acid Bacteria, from food spoilage microflora, exhibiting antimicrobial activity to improve food safety and shelf-life.
Indiolabs Pvt. Ltd.
IndioLabs, a Bangalore based medical device startup, emerging out of the prestigious Stanford-India Biodesign Program, is developing a safe and cost-effective device for soft organ core-tissue biopsy for definitive diagnosis. This device provides unprecedented patient safety through the integration of the unique system that concurrently delivers a hemostatic sealant directly to the site of tissue removal to prevent blood loss. Also the new approach has a multi-functional needle that pierces skin and cuts soft tissue in clean “scooping” action which reduces physician effort and skill by an automated tissue capture mechanism and substantially simplifies the procedure. These technologies will help physicians for the safe and affordable solution for definitive diagnosis of highly dangerous communicable disease like viral hepatitis, which is leading India to a burgeoning silent epidemic.
Sai Siva Gorthi
Dr. Sai SIva Gorthi is an individual academician incubated at the Robert Bosch Center for Cyber Physical Systems (RBCCPS), Indian Institute of Science. He intends on developing an imaging based point-of-care diagnostic device, which can fully-automate the complete work flow of conventional clinical microscopy. A custom designed portable digital microscope augmented with dedicated microfluidic lab-on-chips would enable process automation, as well as, cost-effective implementation of microscopic diagnosis of malaria. Such an inexpensive, portable, and easy-to-use diagnostic device is expected to greatly enhance the quality of health-care available to the rural population of the world.
>String Bio Pvt. Ltd.
A young Bangalore-based venture started in 2013 and currently incubating at Institute of Bioinformatics and Applied Biotechnology (IBAB) that is focused on production of biobased chemicals. The company is using advanced synthetic biology tools to establish fermentation processes for conversion of waste into green chemicals.
Dr. Pillai is an individual academician from THSTI incubated at the National Capital Region Bioscience Cluster (NBC) Incubator at Faridabad. Through the BIG grant he is trying to demonstrate proof-of-concept for a subcutaneous, implantable, drug-delivery device that will auto-deliver the standard anti-TB regimen. This strategy aims to dramatically improve adherence and minimize the need for patient compliance by moving the burden of compliance to the device.
An individual academician currently incubated at Technology Business Incubator, Bits Pilani Hyderabad Campus. He is working on formulation of 3D filaments that are biomaterial based along with the development of a bio-material specific 3D printer that will be tailored to be flexible for cost-effective and eco-friendly 3D printing.
An individual academician incubated at Indian Institute of Horticultural Research, Bangalore. As a part of her BIG-funded project,she is developing processes for commercial scale-up of conventional micro-propagation of banana in suspension cultures using bio-reactors.
An individual entrepreneur working on cordeycep cultures incubated at Sir M Visvesvaraya Institute of Technology, Bangalore. Her BIG project involves extraction and formulation of nutraceutical and therapeutic compounds from cordeycep cultures grown using silkworm pupae.
Dr. Vemula is an individual academician from InStem incubated at C-CAMP. His BIG-funded project involves development of a prophylactic synthetic-enzymes for prevention of chronic pesticide exposure.
Module Innovations Pvt Ltd.
Envisioned to develop a platform technology for rapid detection of pathogens in water, Module Innovations is a recently established start-up based in Pune and incubated at Venture Centre. The company was incorporated just after receiving the BIG grant and they have started their work to establish colour changing nanofiber strips for single and multiple use for selective detection of the Enterohaemmorhagic strains.The start-up aims at providing innovative solutions to Indian market pegged at 500 million USD.
Affigenix Biosolution Pvt. Ltd.
Affigenix Biosolutions Pvt Ltd; an emerging Bangalore based Bioanalytical CRO is using Antibody engineering techniques to develop PAN reactive Trypsin resistant anti-Trypsin antibodies for use in purification of Trypsin, for monitoring Trypsin clearance during biologic's manufacturing and to engineer it as therapeutic antibody for treating pancreatitis, pulmonary emphysema and bronchial asthma.
Robust Herbals Pvt. Ltd.
A Bangalore based start-up with an excellent lab set-up focusing on herbal ingredients & biodegradable polymers for various applications including diagnostics and MR angiography. Through the BIG funds they are trying to develop nanoparticle based blood pool contrast agents for MRI which is biodegradable as well as long circulating making it an attractive candidate for MR angiography.
Geniron Biolabs Pvt. Ltd.
A young start-up working on novel animal vaccines and diagnostics, is focused on development of a technology for eradication of rabies. The team members are former awardees of the BEST Scheme from ABLE and are now taking their idea forward through the BIG scheme and working on the development of a combinatorial DNA vaccine for rabies and immune-contraception for stray dogs.
Dr. Mohana Subramanian
Dr. Mohan is an individual scientist incubating at Translational Research Platform for Veterinary Biologicals, TANUVAS. His BIG-funded project involves development of a novel therapeutic biosimilar for canine parvoviral enteritis. The therapeutic is a recombinant fusion protein that targets the viral receptor and neutralises the virus.
Innaccel Acceleration Services Pvt. Ltd.
InnAccel Acceleration Services private limited is India's first medical technology acceleration company focused on innovation for low and mid-income markets. Dr. Jagdish Chaturvedi is the director of Clinical Innovation at Innaccel and leads the development of affordable medical devices for the company. He leads a team working on a technology called Noxeno, which is a novel, dedicated, easy to use device for effective removal of impacted foreign bodies (NFB) from the nasal cavity in children by GPs and/or health workers in underserved areas. Noxeno was launched recently. Another product, Sinucare - a balloon sinuplasty device for sinusitis, has also been launched.
Biomoneta Research Pvt. Ltd.
Biomoneta designs devices that extract and kill a wide spectrum of microbes (bacteria, fungi and viruses) from contaminated environments. Our novel decontamination technology synergistically combines the principles of electrical engineering and air-flow design with novel anti-microbial materials to achieve microbial kills of over a billion-fold. Our primary focus is preventing the spread of infections in healthcare settings, where technological support for infection control is not widespread. Hundreds of millions of patients are affected by healthcare-associated infections (HAIs) worldwide each year, leading to significant mortality and financial losses for health systems. Nearly 30% of ICU patients succumb to infections due to poor infection control. The increasing numbers of multidrug organisms make “no-drug” solutions, such as decontamination technologies, an important part of the strategy against HAIs.
Kinome Pharma Pvt. Ltd.
A Bangalore based venture started very recently in November of 2013, is focused on neurodegenerative disorders. Their BIG funded project involves development of novel neuroprotective agents for Parkinson's disease. The company’s proprietary small molecule inhibitor compounds are derived from natural products.
Bugworks Research Pvt. Ltd.
Also a spin-off from Cellworks Research, Bugworks Research is a 4th Call BIG grantee and they are a drug discovery company that aims to discover novel treatment options for hospital acquired infections using a systems biology approach. Bugworks uses highly differentiated Systems Biology approaches to identify novel combinations that enhance the action of antibiotics and to discover novel mechanisms that target biofilms.
Shilps Sciences Pvt. Ltd.
A recently established venture, Shilps Sciences is a life science and nano-tech company focused on developing instruments and processes that probe cell mechanical properties. Their BIG funded projects revolves around developing an AFM and microfluidics based detection device for cancer metastasis.
Aten Biotherapeutics Pvt. Ltd.
Aten Biotherapeutics is a young start-up focused on nanotechnology based therapeutics for lysosomal storage disorders and other rare diseases. They recently received funding through BIG to work on nanoparticle based therapeutic for Niemann-Pick Type C Disorder.
Founded in Feb 2014, df3d is focused on developing a platform technology for healthcare solutions using 3d printed medical models and customised 3d printed surgical guides. They are based in Bangalore and are working to towards lowers costs and increasing access for 3d printing in healthcare
Coeo Labs Pvt. Ltd.
Coeo Labs is a young med-tech start-up focused on innovative medical devices for Emergency, Trauma and Critical Care. They have been awarded the BIG grant to take forward preliminary work performed as a part of the AIM Program (Affordable Innovation in MedTech) and develop a device for prevention of Ventilator associated pneumonia (VAP). The proposed device is an efficient secretion system that avoids pooling of secretions in the lungs which caused VAP.
Vital Bioscientific Solutions Pvt. Ltd.
Based out the Madras, Vital Bioscientific Solutions is a very recently established venture founded by a couple of IIT-Madras graduates. Their BIG funded project involves, development of a novel monolayer based parallel artificial membrane permeability assay to determine permeability of chemical entities and drugs. The monolayer coating is bio-mimetic and expected to be more efficient and cost effective as compared to gold standards used in the industry.
Scidogma Research Pvt. Ltd.
Dr. Satya Tapas is an individual entrepreneur incubated at C-CAMP working on a highly sensitive portable microscope for malaria detection. He is working on developing a compact lens system for a battery operated portable microscope that would be able to record the parasite counts in blood smear for further references. He own 2nd prize in ABLE-BEST 2013 and took his idea forward through BIRAC-BIG scheme.
Naga Mohan Kommu
Dr. Naga Mohan Kommu is an individual Entrepreneur and academician from BITS-Pilani, Hyderabad incubated in the Technology Business Incubator there. His team is working to develop an automated diagnostic device for human genetic disorders. This would be a cost-effective and rapid, multiplex ligation probe amplification (MLPA) based detection device for abnormal copy number variants.
Openwater.in Pvt. Ltd.
openwater.in is founded by Dr. Sanjiv Sambandan and is a spinoff from the Flexible Electronics Lab, Department of Instrumentation and Applied Physics, Indian Institute of Science, Bangalore. The main goal of this startup is to provide smart solutions in the area of waste water management.
Yostra Labs Pvt. Ltd.
Yostra is a healthcare technology firm pioneering smart innovations to make healthcare more effective, affordable and sustainable for the cost sensitive developing market. Diabetes is our core focus area and our team is working on ‘Sparsh’, a screening device for Diabetic Peripheral Neuropathy and ‘Kadam’ a therapeutic device for Diabetic Foot Ulcer treatment, both of which have far reaching impact on public health.
CisGEN Biotech Discoveries Pvt. Ltd.
The Technology is to develop animal TB alert Point of care kit an rapid immuno chromatographic test for TB antibody detection with following novel characters The animal TB alert POC contains defined recombinant TB specific proteins (selection based on genomic and proteomics analysis studies) and pathogenic whole TB proteins and non pathogenic whole TB proteins bound to the nitrocellulose membrane using two kit modules. The two kit modules will identifies and differentiates the TB exposure from the NonTB exposure. Detection of exposure to NonTB is essential in Indian animals population as most of them are exposed to environmental Non TB and result in false positive results in the current diagnostics.
Dr. Subhasis Sarangi
Dr. Subhasis Sarangi is an individual academician incubated at the Society for Innovation and Development (SID), Indian Institute of Science. He leads a team intend on developing a new method of detecting how far a patient’s cancer has spread. The device works on pulse induction principle and uses magnetic nanoparticles for sentinel lymph node biopsy procedure, rather than the standard radioactive isotopes and blue dye, which improves safety, accessibility, and reduces treatment cost.
Cleanergis Biosciences Pvt. Ltd.
Cleanergis Biosciences is involved in Research and Development of innovative, high-quality enzymes for food and waste-water-treatment. The company is currently working on some powerful enzymes obtained through microbial sources and using algae based technologies for bioremediation of sugarcane based distillery waste. The company has developed some useful and potent Enzymes. It has adopted protein engineering solutions to get such proteins. It has a comprehensive portfolio of protein expression systems, synthetic biology methods, assay development and validation. They also offer to its clients customized solutions and proprietary technologies. Cleanergis works in partnerships with clients to ensure mutual success.
Dr. Prashant Rathinam
Dr. Prasanth Rathinam received his Doctoral degree from VIT University, Vellore in Renal diseases (Especially Nosocomial Infections). His research interests include cell-cell communication in pathogens/anti-virulence mechanisms/Devise associated nosocomial infections/Biologically improved devises. He is right now working on biofilm associated medical device infections and with the help of the BIG fund he would like to upend the currently available infection prone urinary catheters to anti-infective. He received the Senior Research Fellowship from ICMR and got recognized in many national and international conferences as well.
Spotsense Health Care Solutions Pvt. Ltd
Spotsense in a resident incubate at C-CAMP. It is currently working towards creating simple affordable and accessible diagnostics especially in the field of pediatric medicine. Spittle, the first product by Spotsense is a diagnostic pacifier which has been developed as a platform for saliva based screening of various neonatal health ailments. The first offering on this platform is a rapid diagnostic test for Neonatal Sepsis. The product is currently in prototype stage and expected to be in market by 2018.
Oreva Medicare Research Pvt. Ltd.
Oreva works on a hands free "electronic larynx" which is affordable, aesthetic in appearance with near normal sound quality. It is also working on an alaryngeal speech device to provide near normal speech for laryngectomee patients. Their proposed solution is conceptualized as an affordable device that would have functions of pitch adjustment and variation together with loudness, producing near normal voice. The device would enable the user to operate mobile phones, microphones and other electronic devices. The device would have a hands free design with decreased radiated noise and better cosmetic acceptability. Their product is aimed to be an affordable way to non-surgically rehabilitate patients who have undergone laryngectomy to restore near normal voice.
Terrablue XT Pvt. Ltd.
TerraBlue XT works on technologies to make the lives of people with chronic disorders better. They are a Bangalore-based startup, comprising of a young and dynamic team of engineers, designers, consultants, and researchers led by CEO Dr. Rajlakshmi Borthakur. The greatest feather on TerraBlue XT’s cap is TJay, an award winning device for the prediction, detection and management of people with epilepsy. TJay catapulted the company to fame, when it became one of the top three winners of the Innovate for Digital India Challenge in 2015, supported by Intel and Government of India that saw participation for 1900+ startups and individuals. TJay was quickly followed by Xaant, a wearable that helps practice calm, gives intriguing insights about the state of a person’s mind and shows how to beat stress. With its ability to understand mental health quickly, Xaant, currently in the final prototype stage is expected to create waves in the wellness sector and is poised for release in the global market. TerraBlue XT’s goal is to bridge the treatment gap existing in the country and it will work to make the lives of people safer and better.
Nesa Medtech Pvt. Ltd. is a medical device start-up working towards excellence in the Research & Development of Medical devices for emerging countries specifically India, and believes in pursuing business through innovation and technology. They are developing an accessible, minimally invasive procedure to treat symptomatic uterine fibroids safely and effectively. This can be achieved by ablating fibroids using radio frequency electrode inserted through uterine cavity under real-time guidance of trans-vaginal ultrasound. Use of the local anesthesia and no incision allow this procedure to be performed in the gynaecologist’s office as a day care procedure.
Bagmo Pvt. Ltd.
Blood transfusion facility in rural area is very poor in India. There are various reasons for non-availability of blood in India, Team Bagmo is working towards addressing these issues to eradicate non availability of blood in rural India. Their first product in development is a novel blood bag monitoring solution while blood is transported to rural areas. While transporting the blood bags, cold chain should be maintained. For quality assurance temperature breaches are monitored and documented for each blood bag in their solution. This will in turn increase confidence on blood available for transfusion and also reduce unnecessary wastage of precious blood.
Dr. Shantanu Chakravarti
Dr. Shantanu Chakravarti is a Mechanical Engineer by training and his interests are in medical devices, haptics, controls, and robotics. He is working on developing a Virtual Reality based simulator for training doctors in endoscopy. He studied haptics and simulation related issues for developing an endoscopy simulator during his PhD. They are continuing this work and planning for a commercial venture through the support of BIG funding. Their focus in this work is developing technologies for immersive simulations in endoscopy.
Dr. Kalyani Ramachandran
Dr. Kalyani is a molecular biologist with Ph.D. from Johns Hopkins University, USA. She is developing an affordable, point of care device for comprehensive and early detection of liver disease. Current diagnostics for detection of alcoholic and non-alcoholic liver disease are neither comprehensive nor accurate for all situations and add to increasing costs for patients. Her project will build a technology device utilizing biomarkers miRNA in blood to detect liver disease much earlier, more comprehensively and at an affordable cost bringing clarity and certainty to diagnosis. The goal is to build a point of care device for easy use, eliminating the necessity for trained personnel and laboratories. Successful adoption of the technology will transform the current market, introducing a blood based diagnostic equivalent to the gold standard biopsy.
Dr. Anand Khedkar
Dr. Khedkar is a scientific leader with about 20 years of experience in biotech product development, analytics, formulation and process sciences. He has worked on oral develiery of insulin for over a dacade and made it successfully through phase 2 clinical development. He has been an inventor in multiple patents and authored several publications. His vision is to address unmet patient need through next generation peptide drugs. Towards this objective, he is working to develop a peptide editing platform to specifically deliver peptide drugs orally. Using in silico and in vitro assays, the objective will be to select novel analogues of known peptide drugs that are amenable to oral delivery, without impacting its function.
Giga Builders Pvt. Ltd.
The objective of Giga Builders Pvt. Ltd. is to study plant growth and response under precisely maintained soil moisture status at desired level. Till now, they have made some progress on
1) Development of Load-cell based structure platform with desired structural features to house the potted plants.
2) The other R&D activity is to design and develop embedded electronics controller to capture real-time data of the load-cell assembly.
They are in the process of further testing their first prototype. They aim to develop a minilysimeter device for precise imposition of soil moisture stress. The device has a phenomenal relevance and significance in identifying the crop varieties with improved draught tolerance and productivity.
Empathy Design Labs is a Bangalore-based company working on developing a fetal monitoring device to prevent still births in developing countries. As per WHO report - 2.6 million stillbirths take place every year across the globe. More than 98% of these still births occur in developing countries like India. Empathy is designing a device to prevent stillbirths in developing countries by introducing an affordable, wearable, effective, and non-invasive screening and monitoring tool. Post completing early clinical studies, they plan to introduce the product into the Indian market.
Eyestem is a resident C-CAMP incubatee using stem cell and gene editing technologies to create breakthrough therapies for degenerative diseases of the eye. Age-related macular degeneration (AMD) affects the RPE layer of the retina and ranks third among the global causes of visual impairment. Eyestem’s vision is to create scalable and affordable stem cell therapy for these degenerative eye diseases.
Theevanam Additives & Nutraceuts Pvt. Ltd.
Theevanam Additives & Nutraceuts Pvt. Ltd. is a Start-up company with a commitment for excellence in bringing quality products and technology in food and feed additives sector. They are working on the development of the novel formulation of natural polysaccharide immunity booster for booming Shrimp aqua industry of India. The formulation is expected to efficiently eliminate major infections and stress/morbidity usually encountered in shrimp cultivation at hatcheries as well as open ponds/farms and thereby the formulation will improve the overall productivity.
Luxmatra is working on developing a novel radio-wave responsive, biodegradable nanoparticle platform for image-guided hyperthermia combined with immunotherapy for liver cancers. LuxMatra will focus on developing biodegradable nanoparticles that can trigger hyperthermic response within tumors upon exposure to low-power radio-waves.
Dr. Vishal Rai
Dr. Vishal Rai is a individual entrepreneur whose research interest lies in developing chemical technologies for precision labeling of proteins. His team has developed chemical platforms that can identify and target reactivity hot-spots on the protein surface and enable single-site protein modification.
Snaayu Lifesciences is a resident incubatee working towards isolating and characterizing novel analgesics from cone snail venom. Cone snails are venomous mollusks with around 700 species. A number of pharmacologically active peptides have been isolated from venoms of different species of cone snails. The long term goal of Snaayu Life Sciences is to use cell-based assays to target human disease pathways, particularly the nervous system, with pharmacologically active venom components to generate drug leads.
Prantae is a start-up working on the development of a diagnostic platform for the miR-based detection of pre-eclampsia. Pre-eclampsia (PE) is one of top four causes of maternal deaths during pregnancy. Prantae proposes to translate the potential of identified miRs into an affordable clinical platform for early prediction of PE.
Dr. Rashmi Tambe
Dr. Rashmi Tambe is working towards the development of a device for the early detection of acute and chronic kidney diseases. Almost 30 pct. of all hospital admissions fall in a wide definition of Acute Kidney injury [AKI] and 10 pct. of population worldwide is affected by Chronic Kidney Disease [CKD]. Rashmi proposes to develop an affordable and non-invasive point-of-care device that can detect a particular marker in patients susceptible to renal injury.
Mercuri Biotech is a young Bangalore-based start-up that is developing a novel assay for DNA quantitation. In the conventional systems, quantifying the concentration of DNA and differentiation based on size requires two separate instruments, i.e., UV spectrophotometer and agarose gel electrophoresis. Mercuri proposes to develop a novel technology delta-nuQleo which can simultaneously differentiate band size and provide concentration of the DNA sample instantly in the form of a digital gel. Their technology is cost-effective, with added benefits of no reagents or consumables, no waiting time and only the instrument cost.
Dr. Mahesh H. B.
Dr. Mahesh H. B. is an individual entrepreneur who is interested in isolating secondary metabolites from Bacillus sp. With antimicrobial activity against plant pathogens. Bacillus has been reported to have high biocontrol activity. He aims at commercializing the potential Bacillus strains and characterize the active biocontrol molecule that is stable with respect to its efficacy, production and storage.
Aditya Kadambi is an individual inventor with a background in video technologies and medical imaging. He holds a Master's degree in Computer Engineering from the University of Florida - Gainesville and Bachelor's degree in Engineering from National Institute of Technology - Surat. His team is developing the world's first completely automated Video-EEG system for accurate diagnosis of seizures. Using advanced video and image processing, modern sensors and mobile technologies, this system makes seizure diagnosis more accurate, automated, affordable and accessible.
Neospec Labs are developing a point of care, handheld Bilirubin Meter for accurate detection of jaundice in Neonates. They use direct spectrophotometric principles combined with concepts of biochemistry at the core of their product. The advantages of this method are speed, elimination of centrifugation or other sample preparation, and instrument portability among others.
Cartosense is a medical device startup building products that enable neurosurgeons to plan and safely perform brain surgery through the smallest openings in the skull. Their proprietary technology platform – small form-factor high-accuracy tracking of surgical instruments combined with novel algorithms and workflow improvements – makes high-end surgical navigation compact and affordable for emerging markets. They are also building next gen augmented reality surgical guidance systems that provide the surgeon with tools to visualize, plan and execute small openings and narrow operating corridors with unprecedented spatial understanding, leading to lower postoperative complications, reduced hospitalization time and reduced treatment costs for patients and caregivers.
Hanugen Therapeutics was established to provide high quality oligonucleotides. Hanugen Therapeutics is committed in developing improved methods of oligonucleotide synthesis and for the design of superior modified oligos. Their novel chemistries allow them to address specific genetic diseases by altering the RNA transcription process and thereby modifying protein structure. They specialize in modified oligos, fluorescent probes, long oligos and large scale oligo synthesis. The more modifications that are present in an oligo, and the longer the sequence, the more demanding the synthesis and purification. They are committed to the rare disease community beyond the development of meaningful therapies by delivering advances in oligonucleotide based medicines.
Morphle is a Bangalore-based start-up. They are solving affordable digital pathology by building whole slide scanners & softwares aided diagnostics on top of it.
Equine Biotech is a start-up based at IISc. They are developing point of care diagnostics, including a lateral flow and a PCR chip for field based detection of animal Trypanosomosis (Surra)
Gopi Kadiyala is an individual entrepreneur who is developing a Rapid Point-Of-Care Test Kit to Identify the Bitten Snake Species so that specific anti-snake venom can be used in treatment of snake bite.
Dr. Pious Thomas
Dr. Pious Thomas is an individual inventor with a research background in plant biotechnology and microbiology with the specific areas of plant tissue culture, endophytic microbiology and molecular biology; voluntarily retired recently as Principal Scientist & Head, Division of Biotechnology, ICAR-Indian Institute of Horticultural Research, Bangalore, after 28 years in service. His plan is to test the feasibility of commercial level scaling up of papaya micropropagation in line with the banana tissue culture industry.
MUSE Diagnostics PVT LTD
MUSE Diagnostics PVT LTD is a Bangalore based medical device company founded by Arvind Badrinarayanan & Sumukh Mysore. MUSE is currently working on a futuristic digital stethoscope called TAAL that aims to solve a latent crisis in the medical world. 80% of human death is caused by respiratory and cardiovascular disorders, most of which go undetected due to the lack of screening tools and inconsistent storage of medical data. MUSE's Digital Stethoscope called TAAL, collects sound waves and analyses them across a database of defective medical conditions to provide an affordable yet innovative answer to this global problem. TAAL is loaded with a patented electronic and acoustic design, that makes it robust, portable and easy to use. Features like volume control, multiple filter modes for heart, lungs and bowel sounds, with a 3.5 mm audio output and magnetic charging puts TAAL in a competitive position in the global market.
Log 9 Materials
Log 9 Materials is a nanotechnology company with a determined team of scientists and engineers working on commercializing graphene. The development of new frontiers in graphene synthesis of various forms, reduction and functionalization and designing innovative applications paved the way of the foundation of the company. It is one of the fastest growing innovative R& D start-ups which was awarded ISBA – 2017, the best start-up award in last year.
HarvestWild Organic Solutions
HarvestWild Organic Solutions manufactures bio-surfactants from unutilized soapnuts harvested by tribal communities, thus providing them with livelihood. These bio-surfactants are used in formulating natural and ecofriendly cleaning products. The enterprise is looking to benchmark the performance of bio-surfactant Saponin available in soapnuts with industrial surfactants. It is also looking to further optimize the extraction conditions for improving the yield of saponins from soapnuts so that lower cost of extraction along with optimum yield paves way for its industrial adoption. A major problem with crude saponin extracts is its high cost of purification. The enterprise is looking to create extremely efficient and low cost methods of purification and isolation.
Althion is a health-tech startup developing import-substituting medical/healthcare equipment & devices for India, and eventually the rest of the developing world.
Althion has licensed a patented technology developed by CSIR Indian Institute of Chemical Technology. Building upon this, they are developing two products addressing unmet needs in the Type-1 ultrapure water industry and hemodialysis space respectively. For hemodialysis Althion has developed a low maintenance IoT connected pure water unit that can be remotely monitored and thereby prevent unexpected breakdowns that affect patient care.
Vnir Biotechnologies Pvt Ltd
Vnir Biotechnologies Pvt Ltd is spin-off from Jawaharlal Nehru Centre for Advanced Scientific Research , Bangalore. They are aiming to become global leaders in red/near infra red fluorescence detection. They offer fluorescence molecule to fill the gaps that have not been addressed so far - DNA, reactive oxygen species, mitochondria detection at high efficiencies. Diagnostic kits and devices which can detect alzheimer's, malaria, kidney failure at an early stage are in development. Under the BIG grant, they propose to develop kits for high fidelity collection of cfDNA from blood samples with applications in screening for cancer markers and fetal disorder markers
Dr. Gowsiya Shaik
Dr. Gowsiya Shaik is an individual inventor. She is working towards adapting aeroponic technology for the cultivation of plants with medicinally useful components in their roots. Aeroponic cultivation (Fig. 1) is a soil-less cultivation of plants where roots grow in air in aeroponic chamber and a constant mist provides nutrients and water for growth. Such a precise plant growing condition will overcome several technological gaps like, options to substantially improve the root growth, option for multiple harvests, to avoid any rhizospheric contaminants and finally, an option to provide required environmental factors to enhance the root growth and metabolite production.
Dr. Haripriya Sumana
Dr. Haripriya Sumana is a practicing Consulting General Physician, Diabetologist and Innovator of Advanced Prosthetic Devices for Above knee and Below knee Amputees. Dr. Haripriya's inventions involve novel light weight prosthetic devices involving advanced carbon fiber technology and has 3 Provisional patents with the Indian Patent Office presently. These novel Prosthetic Devices involve unique "double heel system", "light-weight pyramidal composite" and "intralayer reinforcement" which addresses the unmet needs for a smooth transition for patients, elimination of heavy metallic connectors and fittings, thereby offering mid-stance stability and improved comfort to amputees.
Mr Nitin Yadav is an individual innovator developing conformationally restricted short peptides as drugs and drug delivery vehicles for cancer. In the current project, he proposes to develop cationic helical peptides as antimicrobial agents against multidrug-resistant bacteria to combat the emergence and dissemination of antibiotic-resistant microorganisms. Because of the unique multi-targeted mechanism of action of cationic helical peptides, they represent a class of antimicrobials which can act against the drug-resistant bacterial strains, and because of this fact, it may not be easy to develop resistance against this class of compounds. New template peptides, containing conformationally restricting residues in their sequence, α,β-dehydrophenylalanine, will provide longer half-lives and represent a novel class of compounds for therapeutic purposes. Easy synthesis, characterization, and high biocompatibility will also make this novel class of antimicrobials very attractive leads for further development.
Tranalab is developing novel methods for BioSimilars production. Systems with broad platform potential are being examined, with a focus on IP opportunities. Initial propositions are on 'High Value - Low Volume' proteins with potential extension to produce bulk volume proteins at a subsequent stage of technology maturation. Both therapeutic (to treat human disease conditions) and non-therapeutic proteins (Lab/R&D/Analytical/Diagnostic use proteins) are under purview.
Prof. Ram Rajasekharan
Prof. Ram Rajasekharan is an academician with 30-years of experience is now practicing the biochemical principles as an enterprise. Human sucrase enzyme is a key therapeutic target for type 2 diabetes as it has efficient way to control hyperglycaemic conditions. While plant sucrase (invertase) inhibitor modulates the invertase activity thereby accumulates sucrose during plant development. Molecular level understanding of sugarcane invertase inhibitor towards mammalian α-glucosidases was established by his team. A synthetic peptide of 28 amino acids of middle region of the inhibitor has a dose-dependent binding with sucrase. Naturally derived carbohydrate mimics are promising at in vitro conditions and a new horizon towards peptides derived from food are emerging out of this project.
Dr. Suphiya Khan
Dr Suphiya Khan is presently Associate Professor Department of Bioscience and Biotechnology at Banasthali Vidyapith. Dr Suphiya Khan’s path breaking research work on Fluoride removal from drinking water titled “Defluoridation technology for drinking water and tea by green synthesized Fe3O4/Al2O3 nanoparticles coated polyurethane foams for rural communities” was featured (14 August 2017) in the highly respected Nature Journal. She is also emerging as bio entrepreneur with her startup venture Flo Aqua Remedies & Company Ltd founded by her for commercializing this technology.
Carditek Medical Devices Pvt. Ltd.
Dr. H. N. Suma
Dr H N Suma in majorly into Bio-medical research and is working/worked as PI for various funded projects to the tune of 180 lakh majorly in the field of Medical device development. Her Research Interests are: Medical Imaging, Brain Mapping, Neural Networks, Pattern recognition and Affordable medical device development. Under the BIG scheme, she is developing a technology to provide timely help and first aid to accident or mass disaster victims with secure and safe transport to Hospital without waiting for ambulance. She is building a comprehensive and affordable medical trauma kit that can cater to the emergent needs of the accident victims and ensure safe and rapid transport of such persons to the nearest healthcare facility for definitive treatment.
Prakhoj Pvt. Ltd.
Prakhoj Pvt Ltd is a Bengaluru based startup working on malodor management using a novel technology. The product, named Malodorex Activ SLR (MXA-SLR), is a liquid concentrate of nano-complexes and a non-pathogenic bacterial consortium adept in malodor management. The preliminary data from Indian Railways, brewery pubs, clubs and hostels in Bangalore are encouraging. The preliminary studies have been extended to evaluate the technology with competitor products by an NABL laboratory. MXA-SLR was found to be effective for 18-20 hours vis-à-vis 2-5 hours of competitor brands in a single application and also saved 100 L of water at the same time.
Dr. Balasubramanian Natarajan
Dr. Balasubramanian Natarajan an entrepreneur with 15 years of academic and industrial experience in diagnostics. He is interested in the diagnosis of invasive fungal infections in immunocompromised patients admitted under critical care settings. Under the BIG grant, he is developing a culture independent; multiplex PCR that detect 18 different invasive fungi directly from a clinical specimen in a single test. The multiplex PCR amplifies virulence specific genes encompassing 18 clinically relevant invasive fungal pathogens including, 11 different species from Candida genus. The PCR platform will identify amplified products using organism specific probe by hybridization. The final end readouts are obtained by employing Up-Converting nanoparticles (UCNP) – a detection system known for its high sensitivity and specificity with a proposed sample turnaround time of 7hrs.
Autoyos Private Limited
Autoyos is a Bengaluru based DeepTech medical device company that specializes in autonomous medical systems. Autoyos offers comprehensive eye care delivery in non-clinical or resource-poor settings without depending on special infrastructure or skilled manpower. Under the BIG scheme, Autoyos proposes to develop a comprehensive diagnostic device for dry eye disease detection. This will be an affordable, non-contact and smart diagnostic tool that combines multiple methods in one device. The solution will function as a closed loop dry eye care eco-system to enable the needy population to avail required care with the help of intelligent telemedicine.
Dr Deevish N.D.
Dr. Deevish is an entrepreneur cum plastic surgeon having keen interest in developing new medical devices related to wound care. As a fellow at Stanford India Biodesign Fellow 2014, he has co-innovated several medical devices with different teams, which are now at different stages of development and manufacturing. Currently, he is working on a device for rapid healing of chronic wounds and burns using epidermal autografts. He has proposed to develop a product - Epiclose, which is a disposable, easy to use standalone device to produce epidermal autograft embedded dressing that can be directly applied over the wounds to achieve faster healing. It also eliminates the need for prolonged dressings as well as surgical skin graft procedure.
Farmgulp Pvt. Ltd.
Farm Gulp is a Bengaluru based startup working in the sector of industrial biotechnology, secondary agriculture and nutra phyto biotechnology. Their main focus is the value addition of agricultural byproducts and the extraction of natural molecules with applications in a wide range of industries such as food & beverage, cosmetic & skin care, Health care & nutraceuticals, Home appliances etc. using bioprocess techniques. Currently, they are working on the isolation of bioactives viz., EGCG antioxidants and Arecoline etc. from arecanut wash liquid, which is Karnataka’s largest available raw material for the production of active pharmaceutical and nutraceutical ingredients. These products will be applicable in major industries. Farmgulp is using novel chromatographic and membrane separation process to achieve about 95% purity.
VT Ecogreen Technologies Pvt. Ltd.
VT Ecogreen Technologies is a Coimbatore based startup developing eco-friendly technologies for application in the field of food, agriculture, health and environment. Their first product with the brand name “CRONUS” is available in the market. Cronus is a chemical free white pepper produced from dry black pepper using microbial fermentation. The byproducts from this process, such as nutrient rich water and biomanure have great commercial value. Hence, the process is a hygienic method for white pepper production with zero waste. At present, Ecogreen is working on an improvised technology for the production of white pepper by optimization, design and development of a novel enzymatic technology to replace the existing microbial fermentation method to overcome the limitations in the process parameters.
Dr. A Michael
Dr. A. Michael is an academician cum entrepreneur having about 28 yrs of teaching experience in the field of applied sciences of Biotechnology at PSG College of Arts and Science, Coimbatore. He has been working on Chicken egg yolk antibodies since 1998 and has generated antibodies in chicken against various bacterial, viral, fungal infectious agents and against Indian Poisonous Snake Venoms. Currently, he is developing a highly purified, cost effective Chicken Egg Yolk IgY antibody that enables improvement in Food nutrition and Healthcare in Humans and Animals under the BIG grant.
Skyfire Applied Intelligence Pvt. Ltd.
Atom360 (registered as SkyFire Applied Intelligence Pvt. Ltd), is a Bengaluru based startup and an AI-enabled healthcare solution provider using state-of-the-art technologies to develop economical, accessible, and reliable screening solutions by employing technologies such as Artificial Intelligence. At present, they are developing an Artificial Intelligence algorithm that will run on smartphones and can be used to identify potentially malignant disorders like precancerous and cancerous oral lesions by analyzing images captured by the smartphone's camera. Through accessible early detection and treatment, it is possible to reduce treatment costs by at least 20x and treatment time from the current 3 months to less than 10 days while also saving the lives of patients.
Mr Tanmay Sutaria
Mr. Tanmay Sutaria is an entrepreneur and industry veteran with over 20yrs of cross disciplinary experience in design and manufacturing of Medical Electronics, Control Systems and software systems based out of Ahmedabad. Under the BIG scheme, he aims to design and develop a fully indigenous, State of the Art Peristaltic Intravenous Infusion Pump with Communication/IoT Interfaces customized to Indian requirements with the goal of improving basic clinical care standards and nursing efficiency at all healthcare levels.
Seragen Biotherapeutics Pvt. Ltd.
Seragen is a Biotherapeutics company based at Bengaluru that helps IVF specialists, Ob-Gyns and andrologists in treating infertility conditions. Seragen has developed technologies with applications in humans, cattle and agriculture in the Artificial Reproduction space. SeraGel, is a patented novel medium for storage of semen and pollen at ambient temperatures such that their original quality is retained. Leading agri companies like Rasi Seeds have experienced remarkable germination/pollination using Seragel. Seragel is easy and convenient to use for semen storage and shipment and ensures high stability without losing potency, reduced ROS rate, and reduced DNA damage vis-à-vis conventional cryostorage.
Sirfbio Pvt. Ltd.
Sirfbio Pvt Ltd is a startup based at Hyderabad involved in the manufacture of medical appliances and instruments. Under BIG, they are developing an integrated real time PCR system that combines isolation, amplification and detection in a single platform along with automated DNA extraction. The proposed equipment, being an open system, can be designed with various amplification reagents for specific infections like malaria, TB, leishmania etc., and can be implemented in rural dispensaries. The proposed equipment will also have applications in the detection of infections in aquaculture, GMO detection in agriculture and infections in veterinary and small animals.
Dr Manivannan Doraipandian
Dr. Manivannan Doraipandian is a professor turned entrepreneur from SASTRA University, Thanjavur. His areas of interest include Cryptography Wireless Sensor Network Security in Computing Embedded Systems. He is working to establish an IoT network framework to monitor the organoleptic properties of a spoilage biomarker of paddy. The platform technology can collect dataset from various food grain silos at different environmental conditions via cloud and predict spoilage using the edge analytical model that is entirely controlled via a mobile app. This product can avoid food grain wastage in storage spaces and assist in various stages of the supply chain. The proposed IoT node with network infrastructure features facilitates online monitoring of food godowns with a novel custom developed decision-making algorithm.
Lifespark Technologies Pvt. Ltd.
Lifespark Technologies is a young startup specializing in curated solutions for Parkinson's disease. Their solutions help those with Parkinson's live a more independent life and in turn connect patients and their families with medical professionals and caregivers for extended medical care. They propose to create a non-invasive, wearable device based on artificial intelligence and augmented reality to reduce gait deficiencies in Parkinson’s Disease patients. The system will be based on the well established concept of sensory cueing, where certain audio-visual stimuli help patients improve gait and overcome freezing episodes. Therapies such as sensory cueing can complement standard drug therapies and do not reduce in efficiency over time. Cue-based therapy has been shown to produce significant improvement in gait.
Dr. Deepthy Aravindakshapillai
Dr. Deepthy Aravindakshapillai is a material scientist and entrepreneur focused on leveraging the potential of nanotechnology-based innovations in developing clinically translatable biomedical devices. Particularly, the emphasis is on developing localized nanodrug delivery systems for therapeutic applications in clinics. The BIG project utilises an innovative nanotextile-based technology for developing drug eluting self-expanding metallic biliary stents. Nanofibrous textiles laden with the standard-of-care chemodrug Gemcitabine, when integrated with the stents would provide localized and sustained drug delivery for several months. This would help to mitigate biliary obstruction and maintain stent patency for prolonged durations, which is currently an unmet clinical need.
Accord Innovations Pvt. Ltd.
Accord Innovations Pvt Ltd is developing a predictive technology platform for the early detection of critical illnesses. The AKICare device is a novel non-invasive attachment to any traditional urinary foley catheter that provides a new diagnostic tool for real-time & accurate measurement to monitor kidney function. The device can alert clinicians on the onset of acute kidney injury (AKI) during ICU stay and major surgery to intervene & prevent AKI. AKICare also provides active urine tube drain line clearance with finer measurement intervals on minute to minute variability that continuously measures urine flow rate, episodes of oliguria, along with other real-time vital signs like hydration status & urinary oxygen tension (renal hypoxia) to indicate the early onset of AKI.
Aman Aggarwal is a researcher cum entrepreneur from NCBS. His interests include the screening of neurodegenerative diseases using Drosophila. Presently, he is developing a novel, cost effective, rapid in-vivo drug screening platform for neurodegenerative diseases, such as PD, using Drosophila. Drosophila has many advantages, viz. low working cost, short life span of 2 months and strong genetic tools, over traditional model systems, along with having a BBB. Recently, drug discovery pipelines have also established Drosophila as an intermediary in-vivo system for drug screening. This proposed rapid and highly sensitive method of behavioral screening, hence, presents a unique opportunity for in-vivo screening large number of compounds at a reduced cost and higher throughput.
Bioroot Explorations Pvt. Ltd.
Bioroot Explorations is a startup based at Trivandrum in the field of biomedical research and environment protection to improve the quality of human life, expanding to manufacturing of medicines, chemicals, engineering and other consumable products that improve the quality of day to day life. Under the BIG scheme, the team is developing a new, efficient, non-toxic indigenous intravenous nanoparticle lipid emulsion as a contrast agent for imaging lesions. This oily medium works as an effective drug carrier, and tumour-seeking embolic agent, all at once. Most importantly, it is iodinated and can thus be easily visualised using any X-ray based imaging modality such as fluoroscopy or CT.
Zero Plast Labs Pvt. Ltd.
Aditya Kabra is an entrepreneur with 6 yrs of research experience in various domains of basic sciences. He is the Founder and CEO of ZeroPlast Labs, a R&D startup aiming to solve India's plastic pollution problem. Zeroplast is developing single-use, cost-effective, hygienic food packaging products (cups, plates and straw) with bacterial nanocellulose or cellulose nanofibers based coatings that will be compostable in soil as per ISO 17556 and designed for meeting quality and performance standards. These nanocellulose-coated paper products will be the only cost-effective, hygienic, food-safe and quality products in the market that is soil compostable as per ISO 17556. Their first product would be a 100% soil compostable (ISO 17556) coffee cup.
For any further information please contact Dr. Pratibha Boga-Kamat at ccamp_big at ccamp dot res dot in
Centre for Cellular And Molecular Platforms
NCBS-TIFR, GKVK, Bellary Road
Bangalore 560065, India